NCT06089174View on ClinicalTrials.gov

Assessment of the Increased Risk of Infection Following an Ultratrail

NANot yet recruitingINTERVENTIONAL
Enrollment

1,300

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

November 30, 2023

Study Completion Date

December 31, 2023

Conditions
RunningImmune DeficiencyInfections
Interventions
OTHER

Ultra-trail

Questionnaires sent to runners at various pre-race and post-race times (Day3, Day6, Day10, Day14 and Day21)

Trial Locations (1)

97400

CHU Réunion, Saint-Denis

All Listed Sponsors
collaborator

Jean Monnet University

OTHER

collaborator

Hôpital Privé de la Loire- Saint Etienne

UNKNOWN

lead

Centre Hospitalier Universitaire de la Réunion

OTHER

NCT06089174 - Assessment of the Increased Risk of Infection Following an Ultratrail | Biotech Hunter | Biotech Hunter